Relief Therapeutics Holding AG (RLFTF)

[tcm55]

At his last presentation's end, DrJJ wanted Israel to approve their drugs separately and not follow the FDA.?.
I think the EU Trial being set up is for Inhaled which is way beyond the stated start date for recruiting in the US. Nothing posted to CT.gov which should have all Trials, EAP / EUA listed.
Seems Dr JJ is putting alot of effort in 'his' NRX and as stated leaving R+D of Avitadil to RLF, with those costs. No words about the IPO or how RLF fits in. RLFTF is just to pay those Bills and be left out?
No US FDA for Inhaled version recruiting and no definite start date for their Prime Inhaled Treatment.
IV is good for severe cases but any IV, even with a PICK is troublesome when the veins are already an issue. JMO. 3 days of 12 hr infusions? Of course that is better than fatal. But.
The amount of sales for Inhaled use in less severe patients and as a preventative or early treatment is where the $ i$, IMO.
So the best drug to move forward seemed to me to be the Inhaled version. Why no news.